Cargando…
Ratiometric Mass Spectrometry Imaging for Stain-Free Delineation of Ischemic Tissue and Spatial Profiling of Ischemia-Related Molecular Signatures
Mass spectrometry imaging (MSI) serves as an emerging tool for spatial profiling of metabolic dysfunction in ischemic tissue. Prior to MSI data analysis, commonly used staining methods, e.g., triphenyltetrazole chloride (TTC) staining, need to be implemented on the adjacent tissue for delineating le...
Autores principales: | Wang, Zixuan, Yang, Ran, Zhang, Yaxin, Hui, Xiangyi, Yan, Liuyan, Zhang, Ruiping, Li, Xin, Abliz, Zeper |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724055/ https://www.ncbi.nlm.nih.gov/pubmed/34993178 http://dx.doi.org/10.3389/fchem.2021.807868 |
Ejemplares similares
-
Identification of Diagnostic Metabolic Signatures in Thyroid Tumors Using Mass Spectrometry Imaging
por: Mao, Xinxin, et al.
Publicado: (2023) -
Spatiotemporal pharmacometabolomics based on ambient mass spectrometry imaging to evaluate the metabolism and hepatotoxicity of amiodarone in HepG2 spheroids
por: Li, Limei, et al.
Publicado: (2023) -
Evaluation of the tumor-targeting efficiency and intratumor heterogeneity of anticancer drugs using quantitative mass spectrometry imaging
por: Zhang, Jin, et al.
Publicado: (2020) -
Molecular Pathological Diagnosis of Thyroid Tumors Using Spatially Resolved Metabolomics
por: Huang, Luojiao, et al.
Publicado: (2022) -
A targeted neurotransmitter quantification and nontargeted metabolic profiling method for pharmacometabolomics analysis of olanzapine by using UPLC-HRMS
por: Liu, Dan, et al.
Publicado: (2020)